We chose CRP levels, neutrophil counts, platelet counts and hemoglobin levels as biological markers of inflammation in cancer because tumor development assumes a state of chronic inflammation, which explains why CRP level and neutrophil count are elevated in oncological patients [32], as it was also proved by the univariate statistical analysis. This evidence concerns the gene CRP and cancer.